Overview

Safety and Tolerability Study of Cotadutide in Japanese Obese Subjects With Type 2 Diabetes Melitus

Status:
Completed
Trial end date:
2020-07-08
Target enrollment:
Participant gender:
Summary
This is a Phase 1 study designed to assess the safety and tolerability of MEDI0382 (Cotadutide) in Japanese T2DM patients.
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca
Collaborator:
MedImmune LLC